Innovative approaches in the diagnosis of cardiology. "Representatives of the US Ambassador Extraordinary and Plenipotentiary to Uzbekistan and Representatives of the USA U.S. company met .
Abrbot is one of the largest chemical companies in the world and has been four years in the list of Fortune 500. The company, operating since 1881, is engaged in the supply of necessary pharmaceutical products for the development of advanced technologies, the production of tools and medicines, as well as the practice of surgical treatment of cardiovascular disease. < The issues of introduction of innovative solutions created by the company in the health system of Uzbekistan, the implementation of technologies was discussed. The sides exchanged views on the issues of cardiology on the issues of trainings of medical workers. It was noted that the diagnosis of cardiovascular diseases, early diagnostics, in particular, the need to study the U.S. experience in infants.
